We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+10.67%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
AUM
$547M
AUM Growth
-$9.74M
Cap. Flow
-$42M
Cap. Flow %
-7.68%
Top 10 Hldgs %
16.06%
Holding
480
New
78
Increased
86
Reduced
74
Closed
239

Top Buys

Rank Stock Value
1
VFC icon
VF Corp
VFC
+$5.76M
2
ACHN
Achillion Pharmaceuticals
ACHN
+$5.22M
3
COR icon
Cencora
COR
+$4.35M
4
NFLX icon
Netflix
NFLX
+$4.25M
5
SBUX icon
Starbucks
SBUX
+$3.8M

Sector Composition

Rank Sector Weight
1 Healthcare 29.46%
2 Technology 20.64%
3 Consumer Discretionary 10.94%
4 Financials 9.21%
5 Industrials 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHN
26
DELISTED
Achillion Pharmaceuticals
ACHN
$4.89M 0.89%
+551,960
New +$5.22M
NFLX icon
27
Netflix
NFLX
$299B
$4.76M 0.87%
+507,500
New +$4.25M
VTRS icon
28
Viatris
VTRS
$20.4B
$4.75M 0.87%
70,050
-21,820
-24% -$1.54M
TVTX icon
29
Travere Therapeutics
TVTX
$5.2B
$4.75M 0.87%
143,240
-26,740
-16% -$732K
SBAC icon
30
SBA Communications
SBAC
$19.2B
$4.74M 0.87%
41,180
+5,900
+17% +$692K
CORV
31
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$4.74M 0.87%
503,222
+207,868
+70% +$1.94M
NOW icon
32
ServiceNow
NOW
$115B
$4.7M 0.86%
316,400
-81,250
-20% -$1.25M
GPRO icon
33
GoPro
GPRO
$130M
$4.66M 0.85%
88,400
+31,810
+56% +$1.63M
LDRH
34
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$4.48M 0.82%
103,560
-15,910
-13% -$632K
PFE icon
35
Pfizer
PFE
$143B
$4.42M 0.81%
138,886
+43,193
+45% +$1.41M
ICPT
36
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$4.24M 0.78%
17,570
+270
+2% +$71.9K
TT icon
37
Trane Technologies
TT
$100B
$4.19M 0.77%
62,180
+10,040
+19% +$687K
REGN icon
38
Regeneron Pharmaceuticals
REGN
$78.5B
$4.16M 0.76%
8,160
-1,790
-18% -$874K
AVDL
39
DELISTED
Avadel Pharmaceuticals
AVDL
$4.14M 0.76%
195,245
+36,501
+23% +$655K
ICE icon
40
Intercontinental Exchange
ICE
$85.6B
$4.11M 0.75%
91,800
+21,400
+30% +$993K
MBLY
41
DELISTED
Mobileye N.V.
MBLY
$4.1M 0.75%
77,130
+20,600
+36% +$976K
HUBS icon
42
HubSpot
HUBS
$12.2B
$4.05M 0.74%
81,690
+53,450
+189% +$2.45M
DPLO
43
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$4.04M 0.74%
+90,380
New +$3.4M
SBUX icon
44
Starbucks
SBUX
$120B
$4.04M 0.74%
75,370
+74,850
+14,394% +$3.8M
MCO icon
45
Moody's
MCO
$82.8B
$4.01M 0.73%
37,170
-17,690
-32% -$1.9M
AMAG
46
DELISTED
AMAG Pharmaceuticals
AMAG
$3.99M 0.73%
57,730
-22,320
-28% -$1.4M
CXO
47
DELISTED
CONCHO RESOURCES INC.
CXO
$3.91M 0.72%
34,378
+12,780
+59% +$1.55M
EXPE icon
48
Expedia Group
EXPE
$35.4B
$3.77M 0.69%
+34,490
New +$3.57M
BWA icon
49
BorgWarner
BWA
$13.1B
$3.46M 0.63%
69,114
-15,711
-19% -$838K
ASRT
50
DELISTED
Assertio
ASRT
$3.44M 0.63%
2,673
-1,650
-38% -$2.26M

Similar funds

Turner Investments's Q2 2015 Portfolio in Review

As of Q2 2015, Turner Investments held 480 positions worth $547M, down 1.8% from $556M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Turner Investments withdrew a net $42M in Q2 2015, closing 239 positions and reducing 74 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $5.47M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Turner Investments opened a new position in VF Corp worth $5.6M.

  • Turner Investments's largest Q2 2015 buy was VF Corp: 85,226 shares worth $5.6M.
  • Turner Investments added most to Cencora in Q2 2015, an estimated $4.35M increase.
  • Turner Investments's biggest Q2 2015 reduction was Ambarella, cutting an estimated $3.62M.
  • Turner Investments fully exited Alexion Pharmaceuticals in Q2 2015, selling an estimated $5.47M.
  • Turner Investments's ten largest holdings make up 16% of its $547M portfolio in Q2 2015.
  • Turner Investments opened 78 new positions and closed 239 in Q2 2015.
  • Turner Investments's portfolio value fell 1.8% quarter-over-quarter to $547M.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.